KBC Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52K | Hold |
9,632
| – | – | ﹤0.01% | 1635 |
|
|
2025
Q4 | $67K | Buy |
9,632
+4,516
| +88% | +$35.4K | ﹤0.01% | 1523 |
|
|
2025
Q3 | $40K | Hold |
5,116
| – | – | ﹤0.01% | 1695 |
|
|
2025
Q2 | $45K | Sell |
5,116
-3,733
| -42% | -$27.1K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $70K | Hold |
8,849
| – | – | ﹤0.01% | 1679 |
|
|
2024
Q4 | $80K | Buy |
8,849
+3,714
| +72% | +$35.9K | ﹤0.01% | 1683 |
|
|
2024
Q3 | $47K | Hold |
5,135
| – | – | ﹤0.01% | 1740 |
|
|
2024
Q2 | $50K | Buy |
5,135
+1,585
| +45% | +$19.3K | ﹤0.01% | 1623 |
|
|
2024
Q1 | $54K | Hold |
3,550
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q4 | $77K | Hold |
3,550
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q3 | $66K | Buy |
+3,550
| New | +$82.9K | ﹤0.01% | 1239 |
|
|
2023
Q2 | – | Sell |
-18,617
| Closed | -$482K | – | 1519 |
|
|
2023
Q1 | $482K | Hold |
18,617
| – | – | ﹤0.01% | 784 |
|
|
2022
Q4 | $440K | Sell |
18,617
-11,051
| -37% | -$298K | ﹤0.01% | 783 |
|
|
2022
Q3 | $752K | Sell |
29,668
-11,088
| -27% | -$389K | ﹤0.01% | 703 |
|
|
2022
Q2 | $1.35M | Buy |
40,756
+1,726
| +4% | +$73.3K | 0.01% | 613 |
|
|
2022
Q1 | $2.81M | Sell |
39,030
-4,616
| -11% | -$333K | 0.01% | 514 |
|
|
2021
Q4 | $4.01M | Sell |
43,646
-22,786
| -34% | -$2.72M | 0.01% | 485 |
|
|
2021
Q3 | $8.42M | Sell |
66,432
-52,698
| -44% | -$7.67M | 0.03% | 382 |
|
|
2021
Q2 | $19.8M | Sell |
119,130
-77,630
| -39% | -$12.6M | 0.04% | 365 |
|
|
2021
Q1 | $35.8M | Buy |
196,760
+13,022
| +7% | +$3.02M | 0.07% | 275 |
|
|
2020
Q4 | $202M | Buy |
183,738
+58,064
| +46% | +$11.8M | 0.09% | 246 |
|
|
2020
Q3 | $27.6M | Buy |
125,674
+33,232
| +36% | +$7.04M | 0.08% | 235 |
|
|
2020
Q2 | $17.6M | Buy |
92,442
+59,019
| +177% | +$10.3M | 0.06% | 286 |
|
|
2020
Q1 | $5.18M | Sell |
33,423
-29,372
| -47% | -$3.42M | 0.04% | 370 |
|
|
2019
Q4 | $5.26M | Sell |
62,795
-12,404
| -16% | -$944K | 0.03% | 463 |
|
|
2019
Q3 | $5.09M | Sell |
75,199
-5,587
| -7% | -$368K | 0.04% | 439 |
|
|
2019
Q2 | $5.37M | Buy |
80,786
+5,977
| +8% | +$348K | 0.04% | 420 |
|
|
2019
Q1 | $4.16M | Sell |
74,809
-23,594
| -24% | -$1.44M | 0.03% | 451 |
|
|
2018
Q4 | $4.88M | Sell |
98,403
-47,117
| -32% | -$2.88M | 0.05% | 349 |
|
|
2018
Q3 | $12.6M | Buy |
145,520
+58,221
| +67% | +$4.15M | 0.1% | 259 |
|
|
2018
Q2 | $5.07M | Buy |
+87,299
| New | +$4.26M | 0.04% | 399 |
|
Other funds holding TDOC
VPM
VCM
VC
KBC Group's TDOC Position: Q1 2026 in Review
KBC Group held its Teladoc Health (TDOC) position steady in Q1 2026 at 9,632 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.
KBC Group first reported a position in TDOC in Q2 2018 and has held it in 31 quarters since. The position peaked at $202M in Q4 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- KBC Group held 9,632 shares of Teladoc Health worth $52K as of Q1 2026.
- KBC Group left its Teladoc Health share count unchanged in Q1 2026.
- Teladoc Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1635 holding.
- KBC Group first reported a position in Teladoc Health in Q2 2018 and has held it in 31 quarters since.
- KBC Group's Teladoc Health position peaked at $202M in Q4 2020.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.